Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference130 articles.
1. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system;Barnholtz-Sloan;J Clin Oncol,2004
2. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system;Kohler;J Natl Cancer Inst,2011
3. Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?;Toyokawa;Cancer Metastasis Rev,2015
4. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation;Mamon;J Clin Oncol,2005
5. ASCEND-3: A single-arm, open-label, multicenter phase II study of ceritinib in ALKi-naïve adult patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC);Felip;J Clin Oncol,2015
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hirnmetastasen;Pneumologie;2024-01-24
2. Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study;BMC Cancer;2023-10-16
3. Distinct metastatic spread and progression patterns in patients treated with crizotinib for ROS1- and ALK-rearranged non-small cell lung cancer: a single-center retrospective study;Translational Lung Cancer Research;2023-07
4. Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives;Translational Lung Cancer Research;2023-04
5. Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial;Journal of Clinical Oncology;2023-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3